Literature DB >> 24980871

The P2/P2' sites affect the substrate cleavage of TNF-α converting enzyme (TACE).

Sen Liu1, Song Liu2, Yanlin Wang2, Zhaojiang Liao3.   

Abstract

Tumor necrosis factor-alpha converting enzyme (TACE) is a proteinase that releases over eighty soluble proteins from their membrane-bound forms, and it has long been an intriguing therapeutic target in auto-immune diseases, and recently, in cancers. However, a haunting question is how TACE recognizes its substrates. In this work, we applied computational and experimental methods to study the role of the P2 site and the P2' site of the substrate peptide in the substrate cleavage of TACE. In the computational complex model, the sidechains of these residues do not form key interactions with TACE, but experimentally, the mutations at these two positions largely affect the peptide cleavage efficiency in the enzymatic assay. We then showed that the P2/P2' sites could affect the efficiency of the conformation search for the correct peptide orientation, which in turn affects the substrate cleavage efficiency. Our result provides new information to the better understanding of the enzymatic mechanism of TACE, and could be useful in the design of novel TACE inhibitors.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ADAM17; Peptide–protein docking; Substrate recognition; TNF-α converting enzyme

Mesh:

Substances:

Year:  2014        PMID: 24980871     DOI: 10.1016/j.molimm.2014.05.017

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

1.  Expression levels of IL-17 and TNF-α in degenerated lumbar intervertebral discs and their correlation.

Authors:  Xiao-Gang Liu; Hong-Wei Hou; Yi-Lin Liu
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

2.  Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2.

Authors:  Qizhang Li; Zhiying Wang; Qiang Zheng; Sen Liu
Journal:  Comput Struct Biotechnol J       Date:  2020-08-26       Impact factor: 7.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.